Mifepristone

Showing 17-24 of 26 results

Research roundup: January 2023 edition

A systemic review of “no-test” medication abortion, using an allis clamp during IUD placement, a trial of gabapentin for pain management during second-trimester abortions, and at-home urine pregnancy testing for follow-up of immediate management of an undesired pregnancy of unknown location.

Abortion in primary care

How primary care providers can support increased abortion access for all.

Research roundup: June 2022 edition

Effective emergency contraception for individuals with obesity, the need for a reproductive justice lens in contraceptive counseling, a new treatment for bacterial vaginosis, and more.

Research roundup: May 2021 edition

Pre-treatment with mifepristone for pain management in first-trimester surgical abortion care, high patient and provider satisfaction with telemedicine contraceptive counseling, an update to the CDC’s recommendation on self-administered DMPA-SC, and more.

Research roundup: April 2021 edition

Public health benefits of widespread HPV vaccination, potential for IUDs to be placed as emergency contraception 6-14 days after unprotected vaginal sex, etonogestrel implants to help with pelvic pain, and more.

Research roundup: February 2021 edition

Comparable effectiveness of Levonorgestrel and copper IUDs as emergency contraception, use of the Natural Cycles app for fertility awareness contraceptive method, transcutaneous electrical nerve stimulation as highly effective pain management in medication abortion care, and more.

Research roundup: January 2021 edition

Benefits of self-administered DMPA injections, an analysis of prophylactic pain management in medication abortion care, a need for ongoing education for providers on clinical indications for pelvic exams, the potential use of mifepristone as emergency contraception, and more.

Research roundup: December 2020 edition

An analysis of the use of verbal anesthesia vs. oral tramadol for pain management in IUD placement, potential effectiveness of DMPA as a self-bridging emergency contraceptive, the importance of access to PrEP among people at risk of HIV infection through receptive vaginal intercourse, and more.
  • Previous
  • 1
  • 2
  • 3(current)
  • 4
  • Next